Objective: To estimate the prevalence of Pisa syndrome (PS) in patients with Parkinson disease (PD) and to assess the association between PS and demographic and clinical variables.
antiemetics, antidepressants, central cholinesterase inhibitors, lithium carbonate, and other drugs. 10 More recently, PS has also been reported in patients affected by Parkinson disease (PD) after dopaminergic treatment. [11] [12] [13] [14] [15] [16] [17] Two mutually nonexclusive pathophysiologic hypotheses have been advocated: (1) a central hypothesis, supported by both animal studies and clinical findings and related to an imbalance in basal ganglia functioning along with altered sensory-motor integration; and (2) a peripheral hypothesis, referred to as a primary alteration of the musculoskeletal system. 2, 3 The broad variability of PS clinical features renders its classification uncertain and pathophysiologic explanation is still debated. The direction of trunk deviation with respect to the most affected side has been previously investigated with conflicting results. [12] [13] [14] [15] [16] [17] [18] [19] [20] The relationship between drug exposure and occurrence of PS is also uncertain. [10] [11] [12] [13] [14] [15] [16] [17] Finally, no study could detect a relationship with the stage and severity of the disease or systematically assess the prevalence of this condition with the exception of one small study. 21 The aforementioned case series have produced conflicting results and demographic, disease-related, and treatment-related factors associated with PS have not yet been clarified. Therefore, this multicenter cross-sectional study was designed to systematically investigate the prevalence of PS and its relationship with clinical and demographic features in a large cohort of consecutive patients with PD. These data would be relevant to identify at-risk patients and PS-associated symptoms that may benefit from earlier therapeutic strategies.
METHODS In the present multicenter cross-sectional study, consecutive outpatients with PD attending 21 movement disorders Italian tertiary centers between February 2012 and July 2013 were enrolled and underwent standardized clinical evaluation. Patients identified with PS underwent a supplementary evaluation by means of an ad hoc questionnaire and a specific neurologic examination (figure 1). PD was diagnosed according to the United Kingdom Parkinson's Disease Society Brain Bank criteria. 22 Exclusion criteria were as follows: (1) occurrence of other postural deformities (in absence of PS) according to established diagnostic criteria (i.e., camptocormia $45, antecollis $45, or retrocollis) 2 ; (2) concomitant neurologic diseases known to negatively affect posture; (3) a history of major spinal surgery or muscle and/or skeletal diseases; (4) treatment with drugs potentially able to induce PS (neuroleptics other than clozapine or quetiapine and antiemetics with the exception of domperidone) in the 6 months before enrollment; and (5) clinical features consistent with a diagnosis of atypical parkinsonism. 23 In each center, all patients underwent systematic evaluation in a single session by the same neurologist identified before study initiation. Patients were assessed on their usual drug treatment, during the on phase.
The following clinical and demographic variables were recorded in a paper case report form: sex, age, age at PD onset, body mass index, disease duration, PD phenotype (rigid-akinetic, tremordominant, or mixed type), 24 laterality of motor symptoms at PD onset, latency between PD onset and start of antiparkinsonian therapy, and pharmacologic treatment at disease onset and at latest visit. Levodopa equivalent daily dose (LEDD) was calculated according to established criteria. 25 We also evaluated occurrence of falls in the previous month, 26 comorbidities (heart diseases, malignancies, diabetes, hypertension, mental disorders, obesity, metabolic disorders, cerebrovascular diseases, physical trauma), associated medical conditions (osteoporosis, arthrosis, rheumatic diseases, otovestibular disorders), and quality of life by means of Parkinson's Disease Questionnaire-8 (PDQ-8). 27 Unified Parkinson's Disease Rating Scale (UPDRS), Parts I-IV, was used to assess disease severity. 28 Clinical asymmetry was calculated as the differences between the lateralized scores of UPDRS-III items 20-26 of the UPDRS (a difference of $4 points was considered indicative of motor asymmetry). 29 Staging was assessed with the Hoehn and Yahr 30 (H&Y) scale. Trunk deviation was measured by means of a wall goniometer and expressed in degrees. Patients were diagnosed with PS when presenting with a lateral flexion of the trunk of at least 10°and it was almost completely reverted by passive mobilization or supine positioning. 2 According to the angle of the lateral flexion of the trunk, we further divided patients with PS into 2 groups: mild (,20°) and severe ($20°) forms (figure e-1 on the Neurology ® Web site at Neurology.org). Patients with PS were further evaluated to exclude co-occurrence of other postural deformities of the sagittal plane such as camptocormia and/or antecollis, fulfilling the available diagnostic criteria. 2 To disclose possible proprioceptive and vestibular dysfunctions, 17 individuals were tested with a modified version of the stepping test 31 by asking patients to walk forward and backward with eyes closed: the occurrence of a "veering gait" was defined as the progressive deviation (30°or more) toward one side in 3 consecutive trials of 5 m. The following information was gathered for patients with PS, by means of an ad hoc questionnaire and clinical evaluation: latency to develop PS after PD onset, PS duration, PS direction, and presence of metronome sign (defined as an alternate leaning behavior occurring toward both sides). The pattern of PS onset (,1 month: acute; $1 month, ,3 months: subchronic; $3 months: chronic) and its relationship with drug regimen changes were also recorded. We also investigated the following: awareness of trunk leaning by asking the patients whether they felt tilted on one side, while sitting on a chair with the forearms lying on the legs; occurrence of sensory trick (defined as any motor act able to transiently improve posture not due to a mechanical effect); and presence of head compensation (defined as head deviation away from the bending side to preserve a horizontal vision). Chronic dorsal or lumbar pain intensity was ascertained and graded on a visual analog scale graded from 0 (no pain at all) to 10 (excruciating pain). 32 Finally, patients with PS underwent a spine x-ray in a static upright standing position to further disclose orthopedic conditions potentially leading to lateral bending of the trunk.
Standard protocol approvals, registrations, and patient consents. The study was approved by the institutional review boards of the participating centers. All patients were informed about the nature of the study and gave their consent to participate in the study.
Sample size. Sample size was estimated to be between 1,000 and 1,800 patients and was calculated considering different binomial 95% confidence intervals (CIs) for the a priori estimation of PS of 2% based on previous studies, 19, 21 considering a high level of precision (wide 95% CI from 1% to 2%).
Statistical analyses. Missing data were explored. Absolute and relative frequencies were calculated for categorical data and tested by x 2 tests after checking the minimum acceptable number of expected frequencies ($5). Nonnormality of continuous variables was checked by visual inspection of distribution and confirmed by Kolmogorov-Smirnov tests. Since several continuous variables were not normally distributed, values were expressed as means 6 SDs and compared across groups using nonparametric Mann-Whitney U tests. Unadjusted odds ratios (ORs) (95% CIs) between PS and each of the sociodemographic and clinical characteristics were obtained by estimating a series of univariate logistic regression models with PS as the dependent variable and sociodemographic and clinical features as the independent variables.
Subsequently, adjusted ORs (95% CIs) for all possible confounding effects were obtained by estimating a multiple logistic regression model with all sociodemographic and clinical features as the independent variables. Effect modification was also investigated. Independent variables were chosen according to both exploratory analysis results and clinical relevance. Sensitivity analyses were performed to check for robustness of results. First, variables that were not significantly associated in the univariate models were removed from the multiple model and ORs were compared. Second, the effect of missing values was explored by rerunning the univariate logistic regression models on only the subsample with all complete information and by comparing the new unadjusted ORs with the preceding ones. All tests were bilateral at p , 0.05. Statistical analyses were performed using STATA 11.0 (StataCorp LP, College Station, TX).
RESULTS
Clinical features of the patients with PD. A total of 1,631 patients with PD met the eligibility criteria and entered into the study. None of the patients excluded because of the occurrence of other postural disorders had PS (figure 1).
Clinical features of patients with PD and PS. One hundred forty-three patients fulfilled the diagnostic criteria for PS (prevalence 8.8%, 95% CI 7.4%-10.3%). Trunk flexion ranged from 10°to 50°, with an average of 17.0°6 7.4°. Patients were leaning toward the most or the less affected side at a similar proportion. PS appeared 7 6 5 years after PD onset with an average duration of 2.6 6 2.5 years; the majority of patients (69.9%) developed PS in a chronic manner. The remaining clinical characteristics of the patients with PS are provided in table 1. According to the trunk flexion severity, we did not find significant differences between mild and severe PS groups in any of the investigated demographic and clinical variables (table e-1).
Comparison of demographic and clinical features of
patients with PD with and without PS. Patients with PS were older, had lower body mass index, a significantly longer disease duration, more severe disease, and worse quality of life compared with patients who did not have PS. Moreover, patients with PS had higher LEDD and were more likely to be treated with a combination of L-dopa and dopamine agonists (DAs). Osteoporosis and arthrosis were significantly more common in patients with PS (p , 0.001 and p , 0.05, respectively; data not shown). Finally, falls were more likely to occur in the PS group along with veering gait (table 2) .
Clinical and demographic variables associated with PS.
The univariate logistic regression model yielded a significant association of PS with most of the investigated clinical and demographic features (table 3) . After adjusting for all variables in the model, multivariate logistic regression analysis confirmed the above associations with the following variables: H&Y stage (adjusted OR 1.46, 95% CI 1.002-2.13), ongoing antiparkinsonian treatment (L-dopa 1 DA vs L-dopa monotherapy; adjusted OR 1.93, 95% CI 1.10-3.39), associated medical conditions DISCUSSION In this multicenter cross-sectional study enrolling a large cohort of consecutive patients with PD, PS had a prevalence of 8.8%. Patients with PS were older, had a significantly longer disease duration, more severe disease, and worse quality of life. Moreover, they were more likely to be treated with a combination of L-dopa and DA and had higher daily LEDD. Additional new findings in our study were that patients with PS were more likely to report falls, associated medical conditions, and veering gait. The only available study to assess the prevalence of PS in a single-center series of patients with PD found a prevalence of 1.9%, although it was designed for therapeutic purposes. 21 According to a recently proposed criterion, 2 we defined PS as a lateral flexion of the trunk $10°. We did not find any significant difference in clinical and demographic features when we stratified patients with PS in 2 further groups (mild and severe PS) according to severity of lateral bending using a cutoff of 20°. The lack of significant betweengroup differences suggests that the adopted definition of PS can accurately identify patients as a homogeneous clinical group.
We found that patients with PS had more severe disease by H&Y staging. Multivariate logistic regression confirmed this association, suggesting that patients in more advanced PD stages are more likely to develop PS. Tassorelli et al. 20 did not find an association with H&Y in a small sample of patients with PD; nevertheless, they reported that PS was more likely to be found in patients with greater asymmetry subscore, suggesting the possibility that more marked asymmetry of the disease is associated with an increased risk of developing PS. The association of poor quality of life with PS in our cohort supports its clinical effect as motor manifestation of PD; however, this was not confirmed by multivariate logistic regression analysis, suggesting that PS might not be the principal determinant of poor quality of life but other factors associated with longer disease duration are also contributing.
Regarding exposure to dopaminergic drugs, patients with PS were treated with higher LEDD, likely mirroring a more advanced disease stage. Nevertheless, a significant association between PS and concomitant use of L-dopa and DA survived the multivariate logistic regression analysis. This association deserves future studies because DAs have been previously associated with the development of both PS and antecollis. 2 PS developed after drug regimen changes in almost 15% of patients, whereas no correlation to drug exposure or treatment modification was observed in the remaining patients, regardless of the pattern of occurrence. PS might arise from an increase and/or decrease of dopamine agents. [11] [12] [13] [14] [15] [16] [17] [18] It has been proposed that interactions between dopamine and nondopaminergic neurotransmitters are implicated in drug-induced PS. 10, 17 Dopamine exposure might act as a priming factor leading to an imbalance at the striatal level with an increased response in the sensitized, more denervated striatum and promoting PS occurrence in some predisposed persons. 3, 17 However, our data partly contrast with the imbalance hypothesis because we did not confirm previous studies showing that patients with PS lean away from their dominant PD side. 12, [16] [17] [18] [19] [20] Indeed, in cases with a clear motor asymmetry, trunk flexion was contralateral or ipsilateral with a ratio close to 1:1. This suggests that unbalance of basal ganglia output is not the only pathophysiologic mechanism to explain PS occurrence and points to the possible contribution of different mechanisms. Finally, a transient improvement of PS following a "sensory trick" was also reported by a small number of patients, suggesting a dystonic etiology of such condition. Although clinical observations and EMG findings support the dystonic hypothesis, electrophysiologic studies have found contradictory patterns of EMG activity and are not conclusive. [19] [20] [21] 33 This is in keeping with the hypothesis that dystonia may be an early and transient phenomenon. As the postural deformity becomes structured, the dystonic excursion. 2 Co-occurrence of associated medical conditions such as osteoporosis and arthrosis with lower body mass index may further increase the risk of developing abnormal posture as documented in our PS series. Once again, as disease progresses, pathologic changes and fibrosis of soft tissues would in turn promote the transition from compensatoryreversible to structured abnormal posture. 2, 3, 34 Although patients with PS can have impaired perception of their vertical position, 2,3,18 the majority of patients in our series were aware of their leaning posture; however, only half adopted a head compensation to correct the alignment of the visual inflow. Co-occurrence of back pain might have further contributed to emphasize their perception of postural verticality by focusing attention on body image. The clinical observation of patients with PS deviating from a straight line when walking blindfolded (veering gait) might be attributable to the unmasking of an unbalanced vestibular tone resulting from labyrinthine dysfunction. Indeed, an impaired processing of vestibular information has been associated with PS occurrence in patients with PD. 3, 17, 35 In the absence of vestibular testing, we cannot rule out the possibility that mechanical factors destabilizing patients while walking might have contributed to the occurrence of veering gait in our patients with PS. Finally, patients with PS were more likely to report falls. This confirms previous studies showing that postural abnormalities are associated with increased risk of falling, along with a fall history, greater disease severity, and longer disease duration. 36, 37 However, this might point toward an involvement of brainstem structures that have a role in the physiology of axial control, as already hypothesized for camptocormia, which has been linked to oculomotor 38 and sleep 39 impairment as well as atrophic changes of the axial surface of the midbrain. 40 The present study may have several limitations. We excluded other postural abnormalities not combined with PS. Although the co-occurrence of mixed deformities has been investigated in our cohort, we did not find any patients who fulfilled the available diagnostic criteria for camptocormia ($45°) or other rarer postural disorders such as antecollis ($45°) or retrocollis. 2 This might have been caused by our sample size, not enough powered to detect the association with rare phenomena, or by the service-based nature of our cohort carrying the risk of selection bias, which might have led to excluding patients with more severe trunk abnormalities who were unable to attend the outpatient clinic. Moreover, we did not include healthy age-matched controls or patients with PS that arose from other causes. As additional limitations, we defined PS as a lateral flexion $10°, although no consistent diagnostic criteria of PS are available. Because of the cross-sectional design of our study and the lack of laboratory tests, we could not accurately determine the timing of PS onset or the efficacy of the treatment, and we could not speculate on the pathophysiologic mechanisms underpinning PS in PD. We also recognize that for some of the features collected in our population, there is a lack of validated scales; e.g., the awareness of vertical position was discerned solely from a single question regarding the subjective perception of body orientation while sitting. Finally, because of the large study sample included, we were unable to perform cognitive assessment or evaluate whether patients with cognitive impairment were more likely to develop PS.
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